Article
15 Jul 2025
2025 Mid-year Highlights In Canadian Life Sciences IP And Regulatory Law
Nancy Pei
Popular Topics
Food, Drugs, Healthcare, Life Sciences
Intellectual Property
AUTHORS CONTENT
Article
10 Jan 2025
Top Ten Rx IP Update Reads Of 2024
Article
07 Jan 2025
2024 Highlights In Canadian Life Sciences IP And Regulatory Law
Article
12 Jul 2024
2024 Mid-Year Highlights In Canadian Life Sciences IP And Regulatory Law
Article
02 Jul 2024
PMPRB Releases Discussion Guide For PMPRB Phase 2 Consultations On New Guidelines
Article
15 Jan 2024
2023 Highlights in Canadian Life Sciences IP and Regulatory Law
Article
10 Jan 2024
Top 10 Rx IP Update Reads Of 2023
Article
07 Jul 2023
2023 Mid-Year Highlights In Canadian Life Sciences IP And Regulatory Law
Article
06 Jan 2023
COVID-19 Update: CIPO, Federal Courts, Health Canada
Article
06 Jan 2023
New Court Proceedings
Article
05 Jan 2023
2022 Highlights In Canadian Life Sciences IP And Regulatory Law
Article
05 Jan 2023
Top 10 Rx IP Update Reads Of 2022.
Article
15 Dec 2022
Federal Court Of Appeal Dismisses Appeal Challenging Amended Basket Of Comparator Countries In PMPRB Regulations
Article
01 Dec 2022
COVID-19 Update: CIPO, Federal Courts, Health Canada (October, 2022)
Article
31 Oct 2022
PMPRB Finds Ultra-Rare Drug PROCYSBI Is Excessively Priced
Article
12 Oct 2022
Draft Revised PMPRB Guidelines Released For Comment By December 5, 2022
Article
30 Aug 2022
Patented Medicines Pricing – "Status Quo" During The Interim Period
Article
01 Aug 2022
New Court Proceedings - July 2022
Article
01 Aug 2022
COVID-19 Update: CIPO, Federal Courts, Health Canada (July 18, 2022)
Article
25 Jul 2022
2022 Mid-Year Highlights In Canadian Life Sciences IP And Regulatory Law